Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.9 |